Contribution of CXCR4 and SMAD4 in predicting disease progression pattern and benefit from adjuvant chemotherapy in resected pancreatic adenocarcinoma

Autor: Bachet, J.B. *, †, Maréchal, R. , Demetter, P., Bonnetain, F., Couvelard, A., Svrcek, M., Bardier-Dupas, A., Hammel, P., Sauvanet, A., Louvet, C., Paye, F., Rougier, P., Penna, C., Vaillant, J.C., André, T., Closset, J., Salmon, I., Emile, J.F., Van Laethem, J.L.
Zdroj: In Annals of Oncology September 2012 23(9):2327-2335
Databáze: ScienceDirect